✦ LIBER ✦

Enhancement of mouse interferon production by combined treatment of C-243 cells with butyric acid and theophylline

✍ Scribed by Cachard, A.; De Maeyer-Guignard, J.

Book ID: 123497748
Publisher: Elsevier Science
Year: 1981
Weight: 330 KB
Volume: 132
Category: Article
ISSN: 0769-2617
DOI: 10.1016/S0769-2617(81)80001-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A systematic study of interferon product

A systematic study of interferon production by mouse L-929 cells induced with poly(I)-poly(C) and DEAE-dextran

✍ Jan Trapman 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Markedly induced asialoGM1+CD8+T cell pr

Markedly induced asialoGM1+CD8+T cell production and enhancement of antimetastatic activity by interferon β with folic or folinic acid

✍ M. Iigo; Masami Moriyama; Izuru Suzuki; Hiroyuki Tsuda 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 99 KB

Prevention and treatment of L1210 mouse

Prevention and treatment of L1210 mouse leukemia by immunization with xenogenized tumor cells combined with immunostimulation by the P40 fraction of C. Granulosum and chemotherapy

✍ E.H. Relyveld; B. Bizzini; S. Ben-Efraim 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Interferon alpha enhances the cytotoxici

Interferon alpha enhances the cytotoxicity of cytosine arabinoside in HL60 cells by increasing apoptosis and is synergistic with cytosine arabinoside in clinical combination treatment regimens

✍ Bezwoda, W.R.; Seymour, L.; Mansoor, N. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Induction of cell cycle arrest and apopt

Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-α2a, and α-tocopherol in squamous cell carcinoma of the head and neck

✍ Xin Zhang; Zhuo (Georgia) Chen; Fadlo R. Khuri; Dong M. Shin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

## Abstract ## Background. We have previously conducted phase II trials with a combination of 13‐__cis__‐retinoic acid (13‐cRA), interferon‐α2a (IFN‐α2a), and α‐tocopherol (α‐TF) in patients with advanced oral premalignant lesions and locally advanced head and neck cancer in the adjuvant settings